Gastrointestinal Cancer News

Elderly veterans with hepatitis C virus infection had a higher risk for developing cirrhosis or hepatocellular carcinoma compared with younger patients, according to results from a retrospective cohort study.

Patients with colorectal cancer and microsatellite stability receive “no benefit” from immunotherapy, according to J. Randolph Hecht, MD, of the David Geffen School of Medicine at UCLA.

Target enrollment has been reached for the CPP FAP-310 trial, a phase 3 clinical trial evaluating CPP-1X/sulindac combination therapy in adults with familial adenomatous polyposis, according to a press release from the drug maker.

Patients who used a price transparency tool through their health insurance most frequently searched for colonoscopies, mammograms and childbirth services, according to a study published in Health Affairs.

Patients with hepatitis C virus infection who failed interferon-based therapy have an increased risk for hepatocellular carcinoma compared with patients who achieved sustained virologic response, according to recently published data.

Lower-income patients with cancer appeared considerably less likely than higher-income patients to participate in clinical trials, according to findings from a prospective survey study.

Patients with chronic lymphocytic leukemia who survived more than 10 years demonstrated increased risk for other cancers regardless of treatment receipt, according to results of a study conducted at The University of Texas MD Anderson Cancer Center.

The FDA has approved Lumason for use in ultrasonography of the liver to differentiate between hepatic lesions in adult and pediatric patients, according to a press release from the manufacturer.

ASCO will recognize several researchers and scientists during the society’s annual meeting, scheduled for June 3-7 in Chicago.

Coffee consumption may reduce risk for colorectal cancer in a dose–response manner, where even intake of one serving of coffee daily reduces risk, according to an analysis of data from the population-based, case–control Molecular Epidemiology of Colorectal Cancer study conducted in northern Israel.